TRANSFORMING LIVES

APEIRON BIOLOGICS

APEIRON was founded to transform lives and take away the fear of suffering from cancer.

As first Austrian biotech company, APEIRON Biologics developed a cancer immunotherapy product through to market approval in 2017. The cancer-drug Qarziba® is today licensed to our Partner EUSAPharma.

Read more on EUSAPharma.com

RESEARCH & DEVELOPMENT

Since January 2022, the innovative R&D portfolio is operated by the 100% subsidiary invIOs.

invIOs.com
invIOs.com

FURTHER INFORMATION & COMPANY HISTORY